Skip to main content
. 2008 Oct 27;205(11):2483–2490. doi: 10.1084/jem.20080039

Figure 2.

Figure 2.

Heterotopic chimeric Tx-pLN, but not orthotopic Tx-mLN, fail to generate gut-homing T cells in vivo. Cells isolated from OT-I or OT-II Ly5.1 mice were labeled with CFSE and adoptively transferred into mice that received Tx-pLN or Tx-mLN 8 wk before. 1 d later, a single dose of Ova was applied orally or injected s.c. (A) Representative results obtained for α4β7-integrin and CCR9 expression by OT-I T cells (DAPIVα2+Vβ5+CD8+) activated in the mLN, Tx-mLN, and Tx-pLN after oral antigen application and in pLN after s.c. injection of antigen. (B and C) Diagrams depict expression of α4β7-integrin and CCR9 as fold isotype control for OT-I T cells (DAPIVα2+Vβ5+CD8+; B) and OT-II T cells (DAPILy5.1+Vβ5+CD4+; C). All experiments have been performed at least three times with two or more mice per group. Error bars represent SD.